Immunohistochemical study of Expression of Myofibroblasts in Oral Submucous Fibrosis, Oral Squamous Cell Carcinoma and Normal Mucosa by Sivachandran, A
IMMUNOHISTOCHEMICAL STUDY OF EXPRESSION OF 
MYOFIBROBLASTS IN                                              
ORAL SUBMUCOUS FIBROSIS,  
ORAL SQUAMOUS CELL CARCINOMA  
AND NORMAL MUCOSA  
 
 
Dissertation submitted to  
THE TAMILNADU Dr. M.G.R. MEDICAL UNIVERSITY 
 
 
In partial fulfillment for the Degree of  
 















 This is to certify that this dissertation tit led  
“IMMUNOHISTOCHEMICAL STUDY OF EXPRESSION OF 
MYOFIBROBLASTS IN ORAL SUBMUCOUS FIBROSIS, ORAL 
SQUAMOUS CELL CARCINOMA AND NORMAL MUCOSA”  is 
a bonafide dissertation performed by A.SIVACHANDRAN under 
our guidance during the postgraduate period 2009-2012.   
 
 This dissertation is submitted to THE TAMILNADU DR. 
M.G.R MEDICAL UNIVERSITY, in partial  fulfillment for the 
degree of MASTER OF DENTAL SURGERY  in ORAL 
PATHOLOGY AND MICROBIOLOGY, BRANCH VI .  It  has not  


















Dr. K. Ranganathan, MDS, MS (Ohio), PhD 
Professor & HOD 
Department of Oral & Maxillofacial Pathology 
Ragas Dental College & Hospital,  
Chennai 
Guided by 
Dr. Elizabeth Joshua, MDS 
Professor 
Department of Oral & Maxillofacial Pathology 
Ragas Dental College & Hospitals 
Chennai 
 
Dr. S. Ramachandran, MDS 
Principal            
Ragas Dental College & Hospital 
Chennai 
Acknowledgement 
 My heartfelt gratitude to my post graduate teacher Dr. K. Ranganathan, 
MDS, MS (Ohio), PhD,  Professor and Head of Department of Oral and 
maxillofacial pathology, Ragas Dental College and Hospital for his constant, 
support and encouragement and for guiding me throughout my dissertation 
 
 I extend my sincere gratitude to Dr. M. Uma Devi, Professor, Department 
of Oral and maxillofacial pathology Ragas Dental College and Hospital for her 
constant, guidance and support and her advices in completion of my work. 
 
 My sincere thanks to Dr. Elizabeth Joshua, Professor,  Department of 
Oral and maxillofacial pathology Ragas Dental College and Hospital for her 
constant, support and encouragement throughout my study 
 
 Sincere thanks to the principal Dr. Ramachandran and Chairman         
Mr. Kanakaraj, Ragas Dental College and Hospital for their permission to use 
the facilities of the institution. 
 
 I earnestly thank Associate Professor, Dr. T. Rooban, Department of Oral 
and maxillofacial pathology Ragas Dental College and Hospital for his 
encouragement and concern in helping me to completing this study 
 
 I also thank Dr. K.M. Vidya, Dr. N. Lavanya, Dr. C. Lavanya, 
Department of Oral and Maxillofacial Pathology Ragas Dental College and 
Hospital for their constant motivation and support throughout my study. 
 
 
 I am very grateful to our Research Assistant Mrs. Kavitha, Biostatistician 
Mrs. Deepa and Lab Technician Mr. Rajan, Depatment of Oral and Maxillofacial 
Pathology Ragas Dental College and Hospital for their constant help in 
completion of my study. 
 
 I acknowledge gratefully the help of my batch-mates Dr. Femina Kokila 
V, Dr. Janani V, Dr. Shaik Mohamed Shamsudeen, Dr. Prem Karthick B, Dr. 
Soundarya S. I also thank my seniors, juniors for their support and 
encouragement. 
 
 I specially thank my mother, father, wife, family and friends for their 




         
S.NO INDEX PAGE NO. 
1 INTRODUCTION  
2 AIMS AND OBJECTIVES  
3 MATERIALS AND METHODS  
4 STATISTICAL ANALYSIS  
5 REVIEW OF LITERATURE  
6 RESULTS  
7 TABLES AND GRAPHS  
8 PHOTOGRAPHS  
9 DISCUSSION  
10 SUMMARY AND CONCLUSION  
11 BIBLIOGRAPHY  








                                                        
 
                                                                                         





Oral Submucous fibrosis (OSF) is an insidious, chronic disease affecting any part of 
the oral cavity and sometimes the pharynx. Although occasionally preceded by and/or 
associated with vesicle formation, it is always associated with a juxta-epithelial 
inflammatory reaction followed by a fibroelastic change of the lamina propria, with 
epithelial atrophy leading to stiffness of the oral mucosa and causing trismus and 
inability to eat1. There are connective tissue changes present in oral submucous 
fibrosis. The early stage is characterized by a finely fibrillar collagen, dispersed with 
marked edema. The fibroblastic response is produced by fibroblasts which are plump 
of young cells with abundant cytoplasm. In later stages the collagen present in 
connective tissue is moderately hyalinized, the amorphous change starting from the 
juste-epithelial basement membrane. Occasionally, thickened collagen bundles are 
still seen separated by slight residual edema. The fibroblastic response is less marked 
and the fibroblasts are mostly having elongated spindle-shaped nuclei and scanty 
cytoplasm. Oral epithelium in the affected areas is markedly atrophic as compared 
with the thickness of normal oral epithelium. The rete pegs are completely lost. The 
buccal mucosa is normally non-keratinised showing atrophy probably secondary to 
the connective tissue changes.1  
The malignant transformation of OSF was suggested by Murti PR et al (1985) Oral 
submucous fibrosis patients were followed-up for a period of 17 years (median 
observation 10 yr) in Ernakulam District, Kerala, India. Oral cancer developed in five 
(7.6%) patients. The malignant transformation rate in the same sample was 4.5% over 
a 15-yr observation period (median 8 yr). These findings impart a high degree of 
malignant potential of oral submucous fibrosis.2   
In wound healing extracellular matrix is primarily produced by myofibroblasts which 
are contractile cells expressing α-smooth muscle actin (α-SMA). Myofibroblasts play 
an important role in fibrosis, the relationship between myofibroblasts and oral 
submucous fibrosis was established.3  
It is now recognized that the tumor microenvironment makes significant contribution 
to tumor progression. Activated fibroblast endothelial cells, inflammatory cells and 
various extra cellular matrix components are parts of this microenvironment. Most of 
the activated fibroblasts turn into α-smooth muscle actin expressing myofibroblast 
that often represents the majority of tumor stromal cells.4 
Stromal elements play a key role in growth and development of different neoplasms 
and premalignant conditions. Myofibroblasts are the major components and they 
present in stromal tissue during carcinogenesis processes. An increase in the number 
of αSMA-positive myofibroblasts change the distribution pattern during oral 
carcinogenesis process which can be an expression of their role in tumor invasive 
characteristics.5 
Thus, it is necessary to understand the molecular mechanism of oral submucous 
fibrosis and oral cancer progression. Myofibroblasts are responsible for producing a 
variety of factors that are involved in the fibrotic processes. Interruption of their 
development, recruitment or activation could provide a unique therapeutic approach 
to combat fibrosis. The purpose of this study was to evaluate and expression of 




The aim of the study was to evaluate expression of myofibroblasts in oral 
submucous fibrosis and oral squamous cell carcinoma 
OBJECTIVES 
To evaluate the expression of myofibroblasts  
 In Oral Submucous Fibrosis 
 Oral Squamous Cell Carcinoma 
 Normal mucosa 
STUDY SETTING 
 The study was conducted in Department of Oral and Maxillofacial Pathology, 
Ragas Dental College and Hospital, Chennai, using paraffin embedded tissues. 
 It is a cross-sectional study done to evaluate the expression of myofibroblasts 
in oral submucous fibrosis, oral squamous cell carcinoma and normal buccal mucosa 
using immunohistochemistry in formalin fixed, paraffin embedded tissue specimens. 
 
NULL HYPOTHESIS: 
Myofibroblasts are not expressed in both oral submucous fibrosis and oral squamous 
cell carcinoma.  
ALTERNATIVE HYPOTHESIS: 
Myofibroblasts are expressed in both oral submucous fibrosis and oral squamous cell 
carcinoma.  
 
STUDY SAMPLE SIZE 
The study material comprised of 50 formalin fixed, paraffin embedded tissue 
specimens (archival blocks). The samples are divided into 3 groups namely: Group I, 
Group II and Group III. 
Group I: 20 histopathologically confirmed oral submucous fibrosis tissue 
specimens.  
Group II: 20 histopathologically confirmed oral squamous cell carcinoma 
tissue specimens. 








1. Tissue samples Oral submucous fibrosis(n=20), 2 Oral squamous cell 
carcinoma(n=20) and Normal mucosa (n=10) were taken from archival blocks.    
2. Four micron thick sections were cut and used for routine hematoxylin and eosin                                                                                                                            
(H & E) staining and immunohistochemical (IHC) staining. 
3. This project was approved by The Institutional Review Board (IRB) of Ragas 
Dental College and Hospital, Chennai and patient consent was taken. 
 
HEMATOXYLIN & EOSIN STAINING 
REAGENTS 
 Harri’s hematoxylin 




 The slides were dewaxed in xylene and hydrated through graded alcohol to 
water. 
 The sections on the slides were flooded with Harry’s hematoxylin for 5 minutes. 
 The slides were washed in running tap water for 5 minutes. 
 The slides were differentiated in 1% acid alcohol for 5 minutes. 
 The slides were washed well in running tap water for 5 minutes. 
 The tissue sections on the slides were then stained in eosin for 30 seconds. 
 The slides were washed in running tap water for 1 minute. 
 The slides were then dehydrated through alcohol, cleared, mounted and viewed 





 Hot air oven 
 Slide warmer 
 Couplin jars 
 Measuring jar 
 Weighing machine 
 APES coated slides 
 Slide carrier 
 Aluminium foil 
 Micro-pipettes 
 Toothed forceps 
 Electronic timer 
 Beakers 
 Rectangular steel tray with glass rods 
 Sterile gauze 
 Cover-slips 
 Light microscope 
REAGENTS USED 
1. Conc. HCl 
2. Laxbro soln. 
3. APES (3 amino propyl tri ethoxy silane) 
4. Acetone 
5. Citrate buffer 
6. Phospho Buffer Saline (PBS) 
7. 3% H2O2 
8. Deionized distilled water 
9. Nuclear Fast Red 
10. Absolute alcohol 
11. Xylene 
ANTIBODIES USED  
1. Primary antibody –  α-smooth muscle actin 
Biogenex –synthetic NH2 terminal decapeptide of α-smooth muscle actin, Mouse 
monoclonal category and IgG2a immunoglobulins.   
2. Secondary antibody – Biogenex-super sensitive IHC detection system kit (Poly 
Horse Radish Peroxidase -pretitrated anti-species immunoglobulins labeled with 
enzyme polymer, super enhancer reagent, anti mouse monoclonal negative control 
serum, and liquid DAB- Diamino-benzidine-chromogen ) 
IHC PROCEDURE 
PRETREATMENT OF THE SLIDES 
 The slides were first washed in tap water for few minutes 
 The slides were then soaked in detergent solution for 1 hour 
 After 1 hour, each slide was brushed individually using the detergent solution and 
were transferred to distilled water. 
 The slides were washed in two changes of distilled water. 
 The slides were washed in autoclaved distilled water. 
 The slides were immersed in 1 N HCL (100 ml HCl in 900 ml distilled water)     
overnight. 
 The following day slides were taken out of acid and washed in two changes of 
autoclaved distilled water. 
 All the slides were then transferred to slide trays, wrapped in aluminium foil and 
baked in hot air oven for 4 hours at 180 degrees centigrade. 
APES (3 Amino propyl tri ethoxy silane) coating 
Slides first dipped in couplin jar containing acetone for 2 minutes 
Dipped in APES for 5 minutes 
Dipped in two changes of distilled water for 2 minutes each 
Slides left to dry 
PREPARATION OF PARAFFIN SECTIONS 
After the slides were dry, tissue section of 5 micron thickness were made in a rotary 
manual microtome. The ribbons of tissue section were transferred onto the APES 
coated slide from the tissue float bath such that two tissue bits come on to the slide 
with a gap in between. One of the tissue sections was labeled positive (P) and the 
other negative (N). 
PROCEDURE 
The slides with tissue sections were treated with three changes of xylene to remove 
paraffin wax. They were put in descending grades of alcohol and then rehydrated with 
water. Slides were then treated with 3% hydrogen peroxide for 30 minutes to quench 
endogenous peroxidase activity of cells that would otherwise result in non – specific 
staining. The slides were then transferred to citrate buffer and autoclaved for antigen 
retrieval at 15 lbs pressure for 30 minutes. The slides were dipped in 3 changes of 
distilled water for 5 minutes each. Circles were drawn around the tissues, so that the 
antibodies added later on do not spread and are restricted to the circle. The tissues 
were incubated in protein blocking serum for one hour in an enclosed hydrated 
container. Then the slides were wiped carefully without touching the tissue section to 
remove excess of blocking serum. The primary antibody, pre-diluted α-smooth 
muscle actin was added to P tissue on the slide and then to the N, PBS was added. 
The slides were incubated for half an hour . Then the slides were wiped carefully 
without touching the tissue section to remove excess of antibody and washed with 
three changes of cold PBS for 5 minutes. Then a drop of ENVISION horseradish 
peroxidase was added on both the sections and the slides were incubated for 30 
minutes.  Later slides were washed in three changes of cold PBS for 5 minutes in 
each. The slides were wiped carefully without touching the tissue section to remove 
excess PBS. The sections were washed in 3 changes of cold PBS for 5 minutes in 
each. Then the slides were wiped carefully without touching the tissue section to 
remove excess PBS. Then a drop of DAB was added to the sections. Slides were then 
washed in distilled water to remove excess chromogen and counter stained with 
hematoxylin. Then the slides were transferred to 70% alcohol, 100% alcohol and one 
change of xylene. The tissue sections were mounted with DPX. The slides were then 
observed under the microscope. Throughout the procedure care was taken not to dry 
the tissues. 
IHC PROCEDURE FLOW CHART 
APES coated slides with 2 paraffin embedded tissues 
Placed in xylene thrice (5 minutes each) 
Placed in 100% isopropanol (5 minutes) 
Placed in 70% isopropanol (5 minutes) 
Washed in distilled water thrice (5 minutes each) 
Placed in 3% hydrogen peroxide (20 minutes) 
Kept in citrate buffer at pH 6 and autoclaved for antigen retrieval and bench cooled   
for40 minutes 
Washed in distilled water thrice (5 minutes) 
Protein blocking serum added and incubated for one hour  
Primary antibody added to the specimen and incubated for one hour 
Washed in PBS thrice (5 minutes each) 
Secondary antibody added and incubated in an enclosed hydrated container (30 
minutes) 
Washed in PBS thrice (5 minutes each)  
avidin biotin enzyme reagent added and incubated (30 minutes)  
Washed in PBS thrice (5 minutes each) 
DAB added and incubated in an enclosed hydrated container (5 minutes) 
Washed in PBS thrice (5 minutes each) 
Stained with hematoxylin(20 seconds) 
Washed in tap water 
Placed in 70% isopropanol (1 minute) 
Placed in 90% isopropanol (1 minute) 
Placed in 100% isopropanol (1 minute) 
Placed in xylene (1 dip) 
Slides were mounted using DPX 





Statistical analysis was done using SPSS TM software (version 11.5).  p ≤ 0.05 was 
considered to be statistically significant. 
 Chi-square test analysis was done to compare the proportion of myofibroblasts 
expression among the three study groups. 
 The inter-observer variability for the intensity of stain and percentage of cells 
stained was assessed using kappa statistics. 
 
STAINING CRITERIA AND STAINING INDEX CALCULATION METHODS 
 
Calculation of staining intensity (SI) 
No staining scored as 0 (SI 0) 
Staining visible only at 40X scored as 1 (SI 1) 
Staining visible at only at 10X not in 4X scored as 2 (SI 2) 
Staining visible even at 4X scored as 3 (SI 3)  
 
Calculation of percentage of cells (Labeling Index-LI)  
0 positive cells scored as 0 (LI 0) 
1-25% of positive cells scored as 1 (LI 1) 
25-50% of positive cells scored as 2 (LI 2) 
50-100% of positive cells scored as 3 (LI 3) 
 
 
Calculation of staining index 
It is derived from multiplication of staining intensity and percentage of cells. (SI xLI) 
The final score is grouped into no stain, mild, moderate and intense categories. 
1. If score is 0 then it is grouped to no stain category 
2. If the score is 1, 2 then it is grouped to mild category 
3. If the score is 3, 4 then it is grouped to moderate category 

















Schwartz in 1952 described five Indian women from Kenya with a condition of the 
oral mucosa including the palate and the pillars of the fauces which he called 
"atrophica idiopathica mucosa oris". Later on it was termed Oral Submucous Fibrosis 
by Joshi in 1953. 
Paymaster JC in 19566 conducted a clinical study with 650 patients in India and 
concluded that OSF is a potential precancerous lesion and also he described the 
development of slow-growing squamous cell carcinoma in one third of the cases with 
submucous fibrosis.  
 
 Pindborg JJ and Sirsat SM in 1966 1 described OSF (Oral Submucous fibrosis) is 
an insidious, chronic disease affecting any part of the oral cavity and sometimes the 
pharynx. Although occasionally preceded by and/or associated with vesicle 
formation, it is always associated with a juxta-epithelial inflammatory reaction 
followed by a fibroelastic change of the lamina propria, with epithelial atrophy 
leading to stiffness of the oral mucosa and causing trismus and inability to eat. There 
are connective tissue changes present in oral submucous fibrosis. The early stage is 
characterized by a finely fibrillar collagen, dispersed with marked edema. The 
fibroblastic response is produced by fibroblasts which are plump of young cells with 
abundant cytoplasm. In later stages the collagen present in connective tissue is 
moderately hyalinized, the amorphous change starting from the juste-epithelial 
basement membrane. Occasionally, thickened collagen bundles are still seen 
separated by slight residual edema. The fibroblastic response is less marked and the 
fibroblasts are mostly having elongated spindle-shaped nuclei and scanty cytoplasm. 
Oral epithelium in the affected areas is markedly atrophic as compared with the 
thickness of normal oral epithelium. The rete pegs are completely lost. The buccal 
mucosa, normally non-keratinised are showing. The atrophy of the oral epithelium is 
probably secondary to the connective tissue changes. 
 
Ranganathan K, Devi MU, Joshua E et al in 20047 conducted a case control study 
in Chennai. They concluded that (OSF) is a precancerous condition strongly 
associated with the use of areca nut. OSF is significantly associated with use of pan 
masala and pan masala plus areca nut, with or without concurrent alcohol use. 
Tobacco smoking and use of alcohol without use of areca nut containing products is 
not associated with OSF. The areca nut and areca nut-containing agents, with or 
without alcohol or tobacco, are of likely aetiological significance in the development 
of OSF. In particular, individuals having the habit of using pan masala plus alcohol 
are particularly at risk of developing OSF. Tobacco or alcohol were not risk factors 
for OSF to occur, whether taken alone or together.  
 
Ahmad MS, Ali.S.A., Ali. A.S. et al in 20068 studied about the etiological factors 
associated with OSF.  It was found that average betel quid consists of areca nut, lime, 
catechu, and tobacco wrapped in betel leaf approximately 3.5 grams to 4 grams in 
weight. The moisture content of betel quid is 70% and dry weight of tobacco and 
areca nut is about 1.14 grams whereas in pan and gutkha the weighing around 3.5 
grams approximately has 7% of moisture and 3.26 grams of dry areca nut. Hence 
habitual chewer of pan or gutkha is having more chance of developing OSF than 
those who are chewing only betel quid. Due to the established malignant potential and 
the complications of trismus, it is recommended that the patients diagnosed as having 
OSF are followed up regularly. In India, the prevalence of substance use with or 
without other associated habits is increasing as the socioeconomic status of the 
population is increasing. The impact of OSF has thus become an imperative public 
health concern. 
 
Clinical and histopathological classifications of Oral Submucous Fibrosis 
 
Rajendran R in 20039 studied about the clinical and histopathological features. He 
described that the onset of OSF is insidious over a 2 to 5-year period. The prodromal 
symptoms start with a burning sensation in the mouth while taking spicy food, 
appearance of blisters usually seen in the palate, ulcerations or recurrent generalized 
inflammation of the oral mucosa, increased salivation, defective gustatory sensation, 
and dryness of the mouth. There are appearance of small vesicles in the cheek and 
palate. Petechiae are also seen along the vascular dilatations in early stages of the 
disease. External irritant like chilli or areca nut may induce  vascular response due to 
hypersensitivity of the mucosa and formation of petechiae  mostly on the tongue 
followed by the labial and buccal mucosa with no sign of blood dyscrasias or 
systemic disorders. Histologically slightly atrophic epithelium with numerous dilated 
and blood-filled capillaries juxta-epithelially will be present. As the disease 
progresses, the oral mucosa becomes blanched and slightly opaque, and white fibrous 
bands appear. The buccal mucosa and lips may be affected at an early stage although 
it was thought that the palate and the faucial pillars are the areas involved first. The 
oral mucosa is involved symmetrically and the fibrous bands in the buccal mucosa 
run in a vertical direction. The density of the fibrous deposit varies from a slight 
whitish area on the soft palate causing no symptoms to a dense fibrosis causing 
fixation and shortening or even deviation of the uvula and soft palate. The fibrous 
tissue in the faucial pillars varies from a slight submucosal accumulation in both 
pillars to a dense fibrosis extending deep into the pillars with strangulation of the 
tonsils. It is this dense fibrosis involving the tissues around the pterygomandibular 
raphe that causes varying degrees of trismus .The exact site and extent of the fibrosis 
and its role in the causation of trismus are determined by several factors. For 
example, the anatomical and physiological integrity of the underlying musculature is 
vital for the degree of mouth opening. Based on electron microscopical observations. 
Muscle degeneration which is present in OSMF, significantly affect the already 
existing trismus in these patients. Equally important is the involvement of the 
pterygomandibular raphe, a site commonly reported to accentuate the extent of 
trismus. Another factor is the duration of the disease in the affected individuals, 
which depends on the subjective evaluation of signs and symptoms. Current views of 
a protracted and insidious onset of the disease and its very slow progression make any 
sort of objective diagnostic criterion difficult, at least in the earlier stages. A factor 
which seems to be overlooked by many investigators while recording the extent of 
mouth opening is the acuteness of oral symptoms (persistent/ recurrent stomatitis and 
glossitis) at the time of recording. Most investigators agree that in OSMF the patient 
experiences a protracted period of stomatitis and/or glossitis with remissions and 
exacerbations , which must be taken into consideration, together with the age of the 
patient and the extent and site of fibrosis, when recording the extent of trismus. 
Sometimes the fibrosis spreads to the pharynx and down to the pyriform fossae. Upon 
palpation, a circular band can be felt around the entire rima oris, and these changes 
are quite marked in the lower lip . All observers have noted impairment of tongue 
movement in patients with advanced OSMF, but only some have registered an 
atrophy of the tongue papillae. With progressing fibrosis, patients complain of 
stiffening of certain areas of the mucosa leading to difficulty in opening the mouth, 
inability to whistle or blow out a candle and difficulty in swallowing. When the 
fibrosis involves the pharynx, the patient may experience referred pain in the ear. The 
clinical and histological features of OSF are salient and various investigators have 
correlated the same.  
 
Oral Submucous Fibrosis – Etiopathogenesis 
Ranganathan K and Gauri Mishra in 200610 described about different schemes in 
OSF classifications.    Classification of oral submucous fibrosis done on the following 
basis  
1. Classification systems based on clinical features. 
Pindborg JJ (1989) 
Lai DR et al (1995) 
Ranganathan K et al (2001) 
Rajendran R (2003) 
2. Classification systems based on histopathological features.(6) 
Pindborg JJ et al (1966) 
Utsunomia H et al (2005) 
 
3. Classification systems based on clinical features and histopathological 
features. 
Khanna JN et al (2005) 
 
1. Classification based on clinical features. 
Pindborg JJ (1989) divided OSMF based on the physical findings into 3 stages 
Stage 1: Stomatitis includes erythematous mucosa, vesicles, mucosal ulcers, 
melanotic mucosa pigmentation and mucosal petechiae. 
Stage 2: Fibrosis occurs in healing vesicles and ulcers, which is the hallmark of this 
stage.Early lesions demonstrate blanching of the oral mucosa. Older lesions include 
vertical or circular palpable fibrous bands in the buccal mucosa and around the mouth 
opening or lips. This results in a mottled marble like appearance of the mucosa 
because of the vertical, thick, fibrous bands in association with a blanched mucosa. 
Specific findings include reduction of the mouth opening stiff and small tongue, 
blanched and leathery floor of the mouth, fibrotic and depigmented gingiva, rubbery 
soft palate with decreased mobility, blanched and atrophic tonsils, shrunken bud like 
uvula, and sunken cheeks, not commensurate with age or nutritional status. 
Stage 3: Leukoplakia is found in more than 25% of individuals .Speech and hearing 
deficits may occur . 
Lai DR (1995) conducted a study and divided the OSMF based on their inter incisal 
distances 
Group A: Mouth opening greater than 35mm 
Group B: Mouth opening between 30-35mm 
Group C: Mouth opening between 20-30mm 
Group D: Mouth opening less than 20mm. 
Ranganathan K et al (2001) used baseline study on the mouth opening parameters 
of normal patients and divided OSMF patients as 
Group I: Only symptoms, with no demonstrable restriction of mouth opening 
Group II: Limited mouth opening 20mm and above 
Group III: Mouth opening less than 20 mm 
Group IV: OSMF with advanced with limited mouth opening(>7mm and <20mm). 
Precancerous  or cancerous changes seen throughout mucosa. 
This classification includes the common clinical presentations of fibrosis and burning 
sensation along with range of mouth opening would be more convenient and 
appropriate for the clinicians in diagnosis and follow up. 
Rajendran R (2003) reported the clinical features of OSMF as follows 
Early OSMF: Burning sensation in the mouth. Blisters especially on the 
palate,ulceration or recurrent generalized  inflammation of oral mucosa,excessive 
salivation,defective gustatory sensation and dryness of the mouth. 
Advanced OSMF: Blanched and slight opaque mucosa,fibrous bands in buccal 
mucosa running in vertical direction. Palate and faucial pillars are the areas first 
involved. Gradual impairment or tongue movement and difficulty in mouth opening. 
2. Classification based on histopathological features 
Pindborg JJ and Sirsat SM (1996) were the first to divide OSMF depending on only 
histopathological features alone 
Very early stage: Fine fibrillar collagen dispersed with marked oedema. Plump 
young fibroblasts containing abundant cytoplasm. Blood vessels are dilated and 
congested. Inflammatory cells mainly polymorphonuclear leukocytes with occasional 
eosinophils are formed. 
Early stage: Juxtaepithelial area shows early hyalinization. Collagen present are still 
in separate thick bundles. Moderate number of plump young fibroblasts is present. 
Dilated and congested blood vessels. Inflammatory cells are primary lymphocytes, 
eosinophils and plasma cells. 
Moderately advanced stage: Collagen is moderately hyalinized. Thickened collagen 
bundles are separated by slight residual oedema. Fibroblastic response is less marked. 
Blood vessels are either normal or compressed. Inflammatory exudate consists of 
lymphocytes and plasma cells. 
Advanced stage. Collagen is completely hyalanized. Smooth sheets with no separate 
bundles of collagen are seen. Edema is absent. Hyalinized area is devoid of 
fibroblasts. Blood vessels are completely obliterated or narrowed. Inflammatory cells 
found are lymphocytes and plasma cells. 
 
Utsunomiya H, Tilakratne WM, Oshiro K et al (2005) 
Early stage: Large number of lymphocytes in subepithelial, connective tissue, zone 
along with myxodematous changes. 
Intermediate stage: Granulation change close to the muscle layer and hylanization 
appears in subepithelial zone where blood vessels are cmpressed by fibrous bundles. 
Advanced stage: Inflammatory cell infiltrate hardly seen. Number of blood vessels 
dramatically small in subepithelial zone. Marked fibrosis areas with hylaine changes 
extending from subepithelial to superficial muscle layers. Atropic degenerative 
changes start in muscle fibres. 
3.Classification system based on clinical features and histopathological features  
Khanna JN and Andrade NN (1995) developed group of classification for the 
surgical management of OSMF. 
Group I: Very early cases 
Group II: Early cases 
Group III: Moderately advanced cases 
Group IV A: Advanced cases; 
Group IV B: Advanced cases with premalignant and malignant changes. 
 
Maher R, Lee AJ, Warnakulasuriya KA et al in 199411 conducted a case control 
study in OSF. They described the direct role of areca nut in the etiopathogenesis of 
OSF. Experimentally, an alkaloid component of the areca nut, “Arecoline” can induce 
fibroblast proliferation and collagen synthesis and may penetrate the oral mucosa to 
cause progressive cross linking of collagen fibres . 
     
In IARC Monographs (2004)12 They found that the aetiology of OSF is largely 
unknown, there is a relationship between the use of areca nut extract and development 
of OSF prompting the World Health Organization to classify areca nut as a group I 
carcinogen. Areca nut is consumed in various forms with and without tobacco such as 
betel quid (areca nut + slaked lime + betel leaf), pan masala (powdered areca nut with 
additives + flavouring agents + tobacco) and raw areca nut (seeval flakes and kotta 
paaku granules). In India, there are regional variations in the type of areca nut product 
used. However, OSF pathogenesis is multifactorial.  
  P. Rajalalitha and S. Vali in 200513 studied about the various molecular events that 
occur in  OSF. They highlighted the role of locally acting irritants on the oral mucosa. 
The local irritants include areca nut, capsaicin, tobacco, pungent and spicy foods and 
alcohol. Another equally important causative aspect suggested to contribute to OSF is 
the prolonged, chronic deficiency of Iron/Vitamin B complex. Since such nutritional 
deficiencies are more common in females than males, it explains the reason why OSF 
is more prevalent in the female population. This evidence implies that OSF may be 
considered a collagen-metabolic disorder resulting from exposure to areca nuts. 
Collagen is the major structural component of the connective tissues and its 
composition within each tissue needs to be maintained for proper tissue integrity. The 
synthesis of collagens is influenced by a variety of mediators, including cytokines,  
growth factors, lymphokines and  hormones. Transforming growth factor-beta (TGF-
b); TGF-b1, in particular plays a major role in wound repair and fibrosis. This growth 
factor has also been involved in the development of many fibrotic diseases. It induces 
the deposition of extra cellular matrix (ECM) by increasing the synthesis of matrix 
proteins like collagen and decreasing its degradation of collagen by stimulating 
various inhibitory mechanisms. Although TGF-b is essential for healing, 
overproduction leads to scar tissue, and fibrosis. As in other fibrotic diseases, TGF-b 
signaling pathway might be critical for pathogenesis of OSF. There are many reasons 
for chewing betel. It causes euphoria, increases salivation, satisfies hunger, relieves 
tooth pain, etc. The areca nut containing major alkaloids like arecoline, arecaidine, 
arecolidine, guyacoline, and guacine will induce various molecular events via TGF-b 
and eventually results in fibrosis. The important flavonoid components of areca nut 
are tannins and catechins. Arecoline is the most abundant alkaloid. These alkaloids 
undergo nitrosation and give rise to N-nitrosamines, which might have a cytotoxic 
effect on cells. Oral keratinocytes secrete prostaglandins (PGs) in response to areca 
nut extract. This causes inflammatory mediators like activated T cells, macrophage, 
etc emergence and will lead to fibrosis. Persistent tissue inflammation is crucial factor 
for cancer and tissue fibrosis to occur. Thus, it can be considered that induction of 
oral mucosal inflammation by BQ (Betel Quid) ingredients to be a critical event in the 
pathogenesis of OSF.  Cytokines like interleukin 6, tumor necrosis factor (TNF), 
interferon A, etc. and growth factors like TGF-b are synthesized at the site of 
inflammation. Increased susceptibility among individuals who are anemic due to iron 
or vitamin B12 deficiencies has been demonstrated. This could be due to increased 
fragility of the mucosa by which there is more BQ absorption. TGF-b1 is a key 
regulator of ECM (Extra Cellular Matrix) assembly and remodeling. The action of 
TGF-b on the genes implicated in the formation and degradation of the ECM is 
mostly exerted at the transcriptional level through ill defined Intra-cellular pathways. 
An overview of pathogenesis of Oral submucous fibrosis 
 
 
Tilakaratne, M.F. Klinikowski, Takashi Saku et al in 200614 reviewed the etiology 
and pathogenesis of Oral Submucous Fibrosis from data taken from recent 
epidemiological studies. The studies provided evidence that areca nut is the main 
aetiological factor for OSF. A dose-dependent relationship was observed for both 
frequency and duration of chewing areca nut (without tobacco) in the development of 
OSF. Commercially freeze dried products such as pan masala, Guthka and mawa 
have high concentrates of areca nut per chew and appear to cause OSF more rapidly 
than by self prepared conventional betel quid that contain smaller amounts of areca 
nut. The authors hypothesized that the increased collagen synthesis or reduced 
collagen degradation as possible mechanisms in the development of the disease. 
These chemicals appear to interfere with the molecular processes of deposition and/or 
degradation of extracellular matrix molecules such as collagen.In vitro studies on 
human fibroblasts using areca extracts or chemically purified arecoline support the 
theory of fibroblastic proliferation and increased collagen formation that is also 
demonstrable histologically in human OSF tissues. 
 
Oral Submucous Fibrosis – Laboratory Findings 
 
Rajendran R in 20039 studied about the clinical and histopathological features. He 
described about various haematological abnormalities including anemia, increased 
erythrocyte sedimentation rate, eosinophilia, increased gamma globulin, a decrease in 
serum iron and an increase in total iron binding capacity. The percentage saturation of 
transferrin also decreased and a significant reduction in total serum iron and in 
albumin was found. It is doubtful regarding the role of iron deficiency anaemia as the 
cause or the effect of the disorder. A rise in serum mucoproteins, 
mucopolysaccharides and antistreptolysin titre '0' (measured in Todd's unit) has also 
been reported. A significant depression of the lactate dehydrogenase isoenzyme ratio 
(LDH IV / LUH 11) is reported at the tissue level in OSF. 
Rooban, George A et al in 200415 conducted a cytological study of copper in OSF. 
They found that high copper content present habitual areca nut chewers plays a vital 
role in pathogenesis of  OSF. This study evaluates the copper-staining pattern of 
buccal epithelial cells in oral cytological smears of non-chewers, chewers, and OSF. 
Copper appeared as shades of pale red within the cytoplasm of chewers and did not 
show any stain in non-chewers. Intense red stain was seen in OSF smears as dark 
granules within the cytoplasm. They concluded that intense staining of copper in OSF 
buccal smears in areca nut chewers support the role of copper in the pathogenesis of 
OSF. 
 
Malignant transformation of oral submucous fibrosis 
 
Murti PR, Bhonsle RB, Pindborg JJ et al in 19852 conducted in OSF affected 
individuals where 66 patients with oral submucous fibrosis were followed-up for a 
period of 17 yr (median observation 10 yr) in Ernakulam District, Kerala, India. Oral 
cancer developed in five (7.6%) patients. The malignant transformation rate in the 
same sample was 4.5% over a 15-yr observation period (median 8 yr). These findings 
impart a high degree of malignant potential of oral submucous fibrosis. 
 
Radhakrishna Pillai, Prabha Balaram, PhD and Kannan Sankara Reddiar, MS 
in 199216 suggested that OSF is a condition with a high risk of malignant 
transformation. Till date, no conclusive etiologic agent has been identified, although 
plenty of data have been generated on various aspects of the disease. These include 
genetic, carcinogenic, immunologic, viral, nutritional, and autoimmune possibilities, 
all of which also have been implicated in the development of oral cancer 
 
J.H. Jeng, M.C. Chang and L.J. Hahn in 200017 reviewed about the association 
between areca nut  chewing and carcinogenesis. Areca nut  products induce 
mutagenic and genotoxic effects, in addition to inducing preneoplastic as well as 
neoplastic lesions in experimental animals. Areca nut should, thus, be highly 
suspected as a human carcinogen. Toxicity studies relating to areca nut contained 
polyphenols and tannins are not conclusive, with both carcinogenic and anti-
carcinogenic effects being reported. The mutagenicity and genotoxicity of areca 
alkaloids has been detected by many short-term assays. It would thus appear that 
areca nut toxicity is not completely due to its polyphenol, tannin and alkaloid content. 
Reactive oxygen species produced during auto-oxidation of areca nut  polyphenols in 
the BQ-chewer's saliva, are crucial in the initiation and promotion of oral cancer. 
Nitrosation of areca alkaloids also produces areca nut-specific nitrosamines, that have 
been demonstrated to be mutagenic, genotoxic and are capable of inducing tumors in 
experimental animals.  
 
N. Afroz, S.A. Hasan and S. Naseem in 200618 studied about the association 
between areca nut and malignant transformation of OSF. They concluded that 
arecoline in areca nut can induce fibroblast proliferation and collagen synthesis and 
may penetrate the oral mucosa to cause progressive cross linking of collagen. 
Tobacco chewing and smoking are not considered to play a role in the development 
of this disease. 
 
Siddharth Pundir, Susmita Saxena and Pooja Aggrawal in 201019 reported 
development of cancer from OSF in 2 cases.  
In patients with submucous fibrosis, the oral epithelium becomes atrophic and thereby 
becomes more vulnerable to carcinogens. It is now accepted that chewing areca is the 
most important aetiological factor for developing OSF. The atrophic epithelium 
shows first an intercellular edema and later epithelial atypia associated with moderate 
epithelial hyperplasia. From then on, carcinoma may develop any time. It is suggested 
that submucous fibrosis should be regarded as a condition that causes predisposition 
to the development of oral cancer. Here we are presenting two cases of oral 
submucous fibrosis showing malignant potential and development of oral squamous 
cell carcinoma. 
Myofibroblasts in fibrosis and wound healing 
 
Desmouliere.A in 199520 reviewed the factors influencing myofibroblast 
differentiation during wound healing and fibrosis. The author reviewed that the 
granulation tissue fibroblasts develop several ultrastrucutural and biochemical 
features of smooth muscle cells, including the presence of microfilament bundles and 
expression of alpha smooth muscle actin , the actin isoform typical of contractile 
vascular smooth muscle cells. They suggested that when granulation tissue evolves 
into a scar, myofibroblasts containing alpha smooth muscle actin disappear, as a 
result of apoptosis. In contrast myofibroblasts expressing alpha smooth muscle actin 
persist in excessive scarring and in fibrotic conditions. The author concluded by 
stressing on the need for further studies and the factors regulating the phenotype of 
myofibroblasts and understanding their behavior. 
 
Mutsaers and Bishop in 199721 reviewed mechanisms of tissue repair. The overview 
briefly described the process of wound healing and highlighted some of the key 
recent advances in this field of research. It emphasizes the importance of cell-cell and 
cell-matrix interactions, particularly relating to the role of cell surface adhesion 
molecules, and describes developments that have led to a better understanding of the 
dynamic nature of matrix turnover with reference to negative and positive mediators 
that regulate procollagen gene expression and protein production. An important 
component of this was concerned with the development of tissue fibrosis, which 
accompanies a number of disease states and demonstrates remarkable parallels with 
the normal wound healing process; excessive amounts of matrix are laid down but the 
resolution of scarring, which would be anticipated in wound healing, is impaired. 
Since cytokines play an important role in regulating cell function such as 
proliferation, migration and matrix synthesis, it is the balance of these mediators 
which is likely to play a key role in regulating the initiation, progression and 
resolution of wounds. Finally, this review highlights areas of tissue repair research in 
which recent developments have important clinical implications that may lead to 
novel therapeutic strategies. 
 
Jyoji Yamate, Akiko Okado, Mitsuru  Kuwamura et al in 199822 reviewed the 
localization of  myofibroblasts during rat renal interstitial fibrosis following long-
term unilateral ureteral obstruction by immunohistochemical analysis. They  observed 
thatb fibrogenic changes  were seen in the medulla and papilla but not in the cortex of  
the obstructed kidneys. They also added that the myofibroblasts are major cells 
producing extra cellular matrix  such as collagen fibers in fibrogenic lesions and they 
are highly immunopositive for α-smooth muscle actin(SMA). The myofibroblasts are 
characterized by the presence of cytoplasmic myofilaments which are 
immunopositive for SMA and also confirmed this through electron microscopy for 
the presence of myofibroblasts with cytoplasmic actinlike microfilaments in rat 
fibrotic lesions. In their study , they found that as the medullary  fibrosis increases the 
number of SMA-positive cells also sequentially increases 
 
D. W. Powell, R. C. Mifflin, J. D. Valentich et al in 199923 the morphological and 
immunohistochemical properties of myofibroblasts. The myofibroblasts are a unique 
group of smooth-muscle-like fibroblasts that have a similar appearance and function 
regardless of their tissue of residence. The myofibroblasts secrete cytokines( IL1, IL6, 
TNFα, IL10 ),  growth factors (TGF-b ,CSF-1,GM-CSF , PDGF-AA and PDGF-BB) , 
chemokines IL-8 and inflammatory mediators Phospholipase A2 activating protein 
,PGE, ,Prostacyclin. Through these secretions they play an important role in 
organogenesis and oncogenesis, inflammation, repair, and fibrosis in most organs and 
tissues.Platelet-derived growth factor (PDGF) and stem cell factor are two secreted 
proteins responsible for differentiating myofibroblasts from embryological stem cells. 
These and other growth factors cause proliferation of myofibroblasts and 
myofibroblast secretion of extracellular matrix  (ECM) molecules and various 
cytokines and growth factors causes mobility, proliferation, and differentiation of 
epithelial or parenchymal cells. Repeated cycles of injury and repair lead to organ or 
tissue fibrosis The myofibroblasts possess several distinguishing morphological 
characteristics, some of which are present in fibroblasts or smooth muscle cells. They 
display prominent cytoplasmic actin microfilaments (stress fibers), and they are 
connected to each other by adherens and gap junctions . These cells are also in 
contact with the ECM by focal contacts once known as the fibronexus, a 
transmembrane complex made up of intracellular contractile microfilaments and the 
ECM protein fibronectin .  Often, an incomplete basal lamina surrounds the 
myofibroblasts. Gap junctions couple some myofibroblasts to the tissue smooth 
muscle, and the cells are commonly in close apposition to varicosities nerve fibers. 
Immunohistochemical characterization of myofibroblasts is based on antibody 
reactions to two of the three filament systems of eukaryotic cells. These three systems 
are composed of 1) actin, a component of the microfilaments; 2) vimentin, desmin, 
lamin, or glial fibrillary acidic protein (GFAP), members of the intermediate filament 
system; and 3) the tubulins of the microtubules 
 
Veronique Moulin, Francois A. Auger, Dominique Garrel et al in 200024 
investigated the role of wound healing myofibroblasts on re-epithelialization of 
human skin.In human skin, large burned surfaces heal using two concomitant 
phenomena: re-epithelialization and dermal neoformation. Numerous studies report 
the role of interactions between keratinocytes and fibroblasts, but the relationship 
between wound healing myofibroblasts and keratinocytes is not clear, even though 
these two cell types coexist during healing. The authors investigated the influence of 
myofibroblasts on keratinocyte growth and differentiation using an invitro skin 
model. A histological study was performed to determine the speed and quality of 
epithelialization. When the dermis was populated with myofibroblasts, a continuous 
epidermis was formed in 7±10 days. In contrast, with wound healing myofibroblasts 
or without cell in dermis, the complete re- epithelialization never occurred over the 
10-day period studied. After 7 further days of epidermal differentiation, histology 
showed an epidermis more disorganized and expression of basement membrane 
constituents was reduced when wound healing myofibroblasts or no cells were added 
in the dermis instead of fibbroblasts. These results suggest that wound healing 
myofibroblasts are not efficient to stimulate keratinocyte growth and differentiation. 
Treatment of fibroblasts with TGFb1 induced an increase of epidermal cell 
differentiation as seen when myofibroblasts were present. However, this cytokine did 
not change re-epithelialization rate and induced an increase of basement membrane 
matrix deposition in opposition to myofibroblasts. Thus, TGFb1 action is not 
suffcient to explain all the different keratinocyte reactions towards fibroblasts and 
wound healing myofibroblasts. They concluded that myofibroblasts seem to have a 
limited role in the re-epithelialization process and might be more associated with the 
increased extracellular matrix secretion.  
 
Sem H. Phan in 200225 reviewed about the association between pulmonary fibrosis 
and myofibroblasts. In active fibrosis activated fibroblasts phenotypically converted 
into myofibroblasts  which secrete increased amounts of extracellular matrix. The 
extra cellular matrix secreted by  myofibroblasts are type I collagen. They also found 
that transforming growth factor- β provides protection against apoptosis and 
disappearance of myofibroblasts.  They conclude that the appearance and 
disappearance of the myofibroblasts appears to correlate with the initiation of active 
fibrosis and its resolution, respectively. In addition, the myofibroblasts have many 
phenotypic features, which induce much of the pathologic alterations in fibrotic lung 
tissue.Furthermore, the persistence of the myofibroblast may lead to  progressive 
disease and, conversely, its disappearance may be an indicator of resolution. By 
testing the characteristics  of myofibroblasts will yield new therapeutic aspects of 
fibrosis and subsequent treatment of the fibrosis. 
 
Marilena Vered, Izhar Shohat, Amos Buchner et al in 200226 investigated if 
stromal myofibroblasts can contribute to variations in the biological behavior of 
lesions like odontogenic cysts and tumors. Myofibroblasts have the potential to 
facilitate progression of neoplastic epithelial lesions that could contribute to their 
biological behavior. The study was assessed immunohistochemically and the 
frequency of stromal myofibroblasts in different odontogenic cysts and tumors were 
found and it was correlated to their aggressive biological behavior. The study 
included cases of dentigerous cyst (DC, n = 7), odontogenic keratocyst—
parakeratinized type (OKC-P, n = 8), orthokeratinized type (OKC-O, n = 9), 
ameloblastic fibroma/fibro-odontoma (AMF/O, n = 11), unicystic ameloblastoma 
(UAM, n = 6), and solid ameloblastoma (SAM, n = 7). Cases of oral squamous cell 
carcinoma (SCC, n = 5) served as control. Myofibroblast frequency was assessed as 
the number of alpha smooth muscle actin (aSMA)-positive stromal cells in 10 high-
power fields, presented as the mean number of positive cells per field. Counts showed 
that mean number of positive cells in OKC-P was significantly higher than in DC and 
SAM. It was significantly higher than in UAM and AMF/O. Counts in OKC-P and 
SAM were not significantly different from SCC. The high frequency of stromal MF 
in known aggressive odontogenic lesions, such as OKC-P and SAM, implies that MF 
can contribute to the biological behavior of these odontogenic lesions 
Alexis Desmouliere, Ian A. Darby and Giulio Gabbiani in 200327 reviewed the 
retractile and remodeling phenomena accompanying and, in pathologic situations, 
following the healing of an open wound. According to their review mechanical stress 
was crucial for the fibroblast-myofibroblast modulation. Another important point 
clarified is the direct participation of _-SM actin in force generation by the 
myofibroblast. They also stated that during wound healing of a full-thickness rat skin 
wound, cellular retinol-binding protein-1 (CRBP-1) is transiently expressed by a 
significant proportion of fibroblastic cells including myofibroblasts, suggesting that it 
plays a role in the evolution of the granulation tissue.  The activity of myofibroblast 
depends on the combined action of cytokines and growth factors, extracellular matrix 
components, and, importantly, on the development of mechanical tension. Recent 
studies have shown that externally applied mechanical load can lead to the rapid and 
sequential induction of distinct extracellular matrix components in (myo)fibroblasts, 
indicating that extracellular matrix composition is adapted specifically to changes in 
load .The generation of force by the myofibroblast is starting to be elucidated, and 
further work on the mechanisms of stress fiber isometric contraction will furnish tools 
leading to the understanding not only of granulation tissue contraction mechanisms 
but also of the evolution of granulation tissue into a more permanent pathologic 
fibrotic tissue. As discussed above, the transmission of the isometric force produced 
by the myofibroblast is regulated by both stress fiber contractile activity and 
deposition and quality of extracellular matrix. They concluded that understanding the 
interplay between these processes will be important to improve knowledge of several 
physiologic and pathologic situations. 
Gabbiani in 200428 reviewed the evolution of the myofibroblast which is considered 
a key cell for wound healing and fibrotic diseases. Wound healing and 
fibrocontractive diseases are characterized by the presence of a cell called 
myofibroblast that is responsible for pathological tissue remodeling. TGF-beta is the 
main stimulus for the fibroblast/myofibroblast modulation. Alpha-smooth muscle 
(SM) actin, the actin isoform typical of vascular smooth muscle cells, is the main 
marker of the myofibroblastic differentiation and in addition is responsible for the 
high retractile activity of this cell. He concluded that the N terminal sequence of 
alpha-SM actin inhibits myofibroblast contraction invitro and invivo and could 
represent a therapeutic tool in fibrotic diseases. 
Witold W Kilarski, Natalia Jura and Par Gerwins in 200529 studied the migration, 
proliferation and invasive growth activity of myofibroblasts during formation of 
granulation tissue in situations of wound healing, arteriosclerosis and tumor growth. 
They studied the invasive phenotype of myofibroblasts, establishing an assay where 
arterial tissue from chicken embryos was embedded in fibrin gels and stimulated with 
growth factors. Addition of serum, PDGF-BB and FGF-2, but not VEGF-A, resulted 
in an outgrowth of cellular sprouts with a pattern that was similar to the organization 
of cells invading a provisional matrix in an invivo model of wound healing using the 
chicken chorioallantoic membrane. Sprouting cells were defined as myofibroblasts 
based on being a-smooth muscle actin-positive but desmin-negative. Invasive growth 
and sprouting of vascular smooth muscle cells was not limited to chicken cells since a 
similar response was seen when spheroids composed of purified primary human 
aortic smooth muscle cells were embedded in fibrin. This ex vivo model allows 
quantitative analysis of invasive growth and differentiation of vascular smooth 
muscle cells and fibroblasts into myofibroblasts. The method described in this report 
allows studies of myofibroblast differentiation and matrix invasiveness and can be 
complementary to known invitro models design to study myofibroblast dependent 
force generation in three-dimensional matrices. 
H.E. van Beurden, J.W. Von den Hoff, R. Torensma, J.C. Maltha et al in 200530 
discussed the role of myofibroblasts in palatal wound healing. Wound contraction and 
subsequent scar tissue formation, during healing of these surgical wounds, contribute 
largely to these growth disturbances. Fibroblasts initiate wound contraction, but 
proto-myofibroblasts and mature myofibroblasts are by far the most important cells in 
this process. Myofibroblasts are characterized by their cytoskeleton, which contains 
alpha-smooth-muscle actin. Additionally, their contractile apparatus contains bundles 
of actin microfilaments and associated contractile proteins, such as non-muscle 
myosin. This contractile apparatus is thought to be the major force-generating 
element involved in wound contraction. After closure of the wound, the 
myofibroblasts disappear by apoptosis, and a less cellular scar is formed. A reduction 
of contraction and scarring might be obtained by inhibition of myofibroblast 
differentiation, stimulation of their de-differentiation, stimulation of myofibroblast 
apoptosis, or impairment of myofibroblast function and also reviewed the role of 
myofibroblasts in palatal wound healing. The authors postulated that the surgical 
closure of orofacial clefts is considered to impair maxillary growth and dento-alveolar 
development. Wound contraction and subsequent scar tissue formation, during 
healing of these surgical wounds, contribute largely to these growth disturbances. The 
potential to minimize wound contraction and subsequent scarring by clinical 
interventions depends on the surgeon's knowledge of the events responsible for these 
phenomena. Fibroblasts initiate wound contraction, but proto-myofibroblasts and 
mature myofibroblasts are by far the most important cells in this process. 
Myofibroblasts are characterized by their cytoskeleton, which contains alpha-smooth-
muscle actin. Additionally, their contractile apparatus contains bundles of actin 
microfilaments and associated contractile proteins, such as non-muscle myosin. This 
contractile apparatus is thought to be the major force-generating element involved in 
wound contraction. After closure of the wound, the myofibroblasts disappear by 
apoptosis, and a less cellular scar is formed. A reduction of contraction and scarring 
might be obtained by inhibition of myofibroblast differentiation, stimulation of their 
de-differentiation, stimulation of myofibroblast apoptosis, or impairment of 
myofibroblast function. 
 
Brigham C. Willis, Roland M. duBois, and Zea Borok in 200631 reviewed about 
the origin and postulated that myofibroblasts are of epithelial origin during fibrosis in 
the lung. They believed that inflammation and chronic fibrosis, especially in diseases 
such as idiopathic pulmonary fibrosis/usual interstitial pneumonia, are often 
dissociated and that inflammation is neither necessary nor sufficient to induce 
fibrosis. The origin of the primary effector cell of fibrosis in the lung, the 
myofibroblast, is not clearly established. Although conversion of resident fibroblasts 
and differentiation of circulating bone marrow–derived progenitors likely play a role, 
the possible contribution of alveolar epithelial cells (AECs), through a process termed 
epithelial–mesenchymal transition” (EMT), has only recently received consideration. 
A process by which epithelial cells lose cell–cell attachment, polarity and epithelial 
specific markers, undergo cytoskeletal remodeling, and gain a mesenchymal 
phenotype; EMT plays a prominent role in fibrogenesis in adult tissues such as the 
kidney. The authors summarized the evidence supporting a central role for EMT in 
the pathogenesis of lung fibrosis, the potential for EMT in AECs in vitro and in vivo 
and role of transforming growth factor-1 in this process, and the implications of 
epithelium-driven fibrosis on future research and treatment. 
 
Christophe Helary, Ludmila Ovtracht, Bernard Coulomb et al 200632 studied the 
dense fibrillate collagen matrices and the behavior of myofibroblast during wound 
healing. Human dermal fibroblasts were seeded onto three-dimensional fibrillar 
collagen matrices and then migrated into the collagen network and differentiated into 
myofibroblasts. In order to evaluate the use of collagen matrices as model systems for 
studying myofibroblast phenotype during wound healing, myofibroblast behaviour 
migrating into dense or loose matrices was compared. The effect of collagen 
concentration on cell morphology, remodelling, proliferation and apoptosis of human  
myofibroblasts was evaluated. Myofibroblasts within dense collagen matrices (40 
mg/ml) were spindle shaped, similar to cells observed during tissue repair. In 
contrast, cells within loose matrices (5 mg/ml) were more rounded. Matrix hydrolysis 
activities (MT1-MMP and MMP2) did not differ between the two collagen 
concentrations. The myofibroblast proliferation rate was measured after 24 h 
bromodeoxyuridine incorporation (BrdU). Cells in dense collagen matrices 
proliferated at a higher rate than cells in loose matrices at each culture time point 
tested. Apoptotic cells were only detected in dense matrices from day 21 onwards 
when cells had already migrated into the collagen network. These results showed  that 
a high collagen concentration has a stimulatory effect on myofibroblast proliferation 
and apoptosis, two important events in wound healing. Thus, dense matrices can be 
used to create controlled conditions to study myofibroblast phenotype. 
 
Boris Hinz in 200733 reviewed the formation and function of the myofibroblast 
during tissue repair. The authors said that it is generally accepted that fibroblast-to-
myofibroblast differentiation represents a key event during wound healing and tissue 
repair. The high contractile force generated by myofibroblasts is beneficial for 
physiological tissue remodeling but detrimental for tissue function when it becomes 
excessive such as in hypertrophic scars, in virtually all fibrotic diseases and during 
stroma reaction to tumors. Specific molecular features as well as factors that control 
myofibroblast differentiation are potential targets to counteract its development, 
function, and survival. Such targets include smooth muscle actin and more recently 
discovered markers of the myofibroblast cytoskeleton, membrane surface proteins, 
and the extracellular matrix. Moreover, intervening with myofibroblast stress 
perception and transmission offers novel strategies to reduce tissue contracture. Stress 
release leads to the instant loss of contraction and promotes apoptosis. 
   
Mytien T. Goldberg, Yuan-Ping Han, Chunli Yan in et al 200734 suggested that 
the cause for abnormal wound healing could be due to TNF-α which suppresses α-
smooth muscle actin expression in human dermal fibroblasts. Abnormal wound 
healing encompasses a wide spectrum, from chronic wounds to hypertrophic scars. 
Both the conditions are associated with an abnormal cytokine profile in the wound 
bed. In this study, the authors sought to understand the dynamic relationships between 
myofibroblast differentiation and mechanical performance of the collagen matrix 
under tissue growth factor–β (TGF-β) and tumor necrosis factor–α (TNF-α) 
stimulation. We found TGF-β increased α-smooth muscle actin (α-SMA) and TNF-α 
alone decreased the basal α-SMA expression. When TGF-β1 and TNF-α were both 
added, the α-SMA expression was suppressed below the baseline. Real-time PCR 
showed that TNF-α suppresses TGF-β1-induced myofibroblast (fibroproliferative) 
phenotypic genes. The  results further showed that TNF-α inhibits TGF-β1-induced 
Smad-3 phosphorylation via Jun N-terminal kinase signaling. Mechanical testing 
showed that TNF-α decreases the stiffness and contraction of the lattices after 5 days 
in culture. The authors finally concluded that changes in α-SMA, collagen, and 
fibronectin expression result in decreased contraction and stiffness of collagen 
matrices.  
 
Qiong Gan, Tadashi Yoshida, Jian Li et al in 200735 studied about the difference in 
the transcriptional mechanism for expression of α smooth muscle actin by smooth 
muscle cells and myofibroblasts. They studied that myofibroblasts are induced in 
multiple pathological state such as the granulation tissue of contracting wounds, 
fibroproliferative diseases and play a major  role in the inflammatory response. In 
addition, both smooth muscle cells and myofibroblasts contribute to a wide range of 
human diseases including vein graft remodeling, tumor metastasis and myocardial 
remodeling accompanying renovascular hypertension. They found that both smooth 
muscle cells and myofibroblasts express α smooth muscle actin and expression, it can 
be distinguished by different transcriptional mechanisms involving  MCAT (a gene 
sequence) elements 
 
Bin Li a, James H.-C. Wang in 200936 reviewed the role fibroblasts and 
myofibroblasts in  wound  healing and fibrosis and they measured the contractile 
force exerted by fibroblasts and myofibroblasts . Fibroblasts are one of the most 
abundant cell types in connective tissues. These cells are responsible for tissue 
homeostasis under normal physiological conditions. When tissues are injured, 
fibroblasts become activated and differentiated  into myofibroblasts, which generate 
large contractions and actively produce extracellular matrix (ECM) proteins to 
facilitate wound closure. Both fibroblasts and myofibroblasts  are involved in wound 
healing by generating traction and contractile forces, respectively, to enhance wound 
contraction.  Myofibroblasts  are an intermediate cell type between fibroblasts and 
smooth muscle cells (SMCs). Myofibroblasts start to appear in the early phase of 
granulation tissue formation, become abundant in the proliferation phase of wound 
healing, and progressively disappear in the later stage of healing, possibly by an 
apoptotic mechanism. Myofibroblasts have ultra-structures  distinctive from those of 
fibroblasts, including extensive cell-matrix adhesions, abundant intercellular adherens 
and gap junctions, and bundles of contractile cytoplasmic microfilaments Multiple 
sources of myofibroblasts exist in order to meet the temporarily high demand for 
contractile cells in wound repair. Myofibroblasts in skin wounds are derived  from 
fibroblasts in the dermis, subcutaneous tissues surrounding the wound,  pericytes and 
vascular  smooth muscle cells which play  important role  in vascular wound healing . 
There has been evidence that myofibroblasts may be derived from tubular epithelial 
cells through epithelial mesenchymal transition (EMT). The main function of 
myofibroblasts is to synthesize ECM proteins, collagen types I-VI and XVIII, 
glycoproteins, and proteoglycans for normal growth, differentiation, andn repair. 
Myofibroblastsn  secrete many other matrix molecules including laminin and 
thrombospondin, glycosaminoglycans (GAGs), hyaluronic acid (HA), and heparan 
sulfuate (HS), as well as matrix-modifying proteins such as matrix metalloproteinases 
(MMPs) and tissue inhibitor of metalloproteinases (TIMPs). Myofibroblasts  also 
generate contractile forces which bring together the edges of an open wound and 
therefore facilitate wound closure. However, excessive myofibroblast activities, 
including excessive contraction and over-production of ECM are also the major 
causes of tissue fibrosis and scar formation. 
 
Marcello Guarino MD, Antonella Tosoni BSc, Manuela Nebuloni MD in 200937 
reviewed the  contribution of epithelium to organ fibrosis. Fibrosis is a complex 
response initiated to protect the host from an injurious event. It involves massive 
deposition of matrix by an expanded pool of fibrogenic cells, disruption of the normal 
tissue architecture, and parenchymal destruction. Fibroblasts, the effector cells of 
matrix production, when engaged in fibrogenesis, display the highly activated 
phenotype characteristic of myofibroblasts. Although proliferation of pre existing 
stromal fibroblasts, emerging evidence seems to indicate that an important number of 
matrix-producing fibroblasts/myofibroblasts arises through a mechanism of 
epithelial-mesenchymal transition. Through this process, epithelial cells would lose 
intercellular cohesion and would translocate from the epithelial compartment into the 
interstitium where, gaining a full mesenchymal phenotype, they could participate in 
the synthesis of the fibrotic matrix. Epithelial mesenchymal transition is induced by 
the integrated actions of many stimuli including transforming growth factor-β and 
matrix-generated signals that are also known to be implicated in inflammation, repair 
responses and fibrosis. The authors suggested markers of epithelium undergoing 
epithelial mesenchymal transition include loss of E-cadherin and cytokeratin; de novo 
expression of fibroblast specific protein 1/S100A4, vimentin, and α-smooth muscle 
actin; basement membrane component loss; and production of interstitial-type matrix 
molecules such as fibronectin and type I/III collagen. 
 
Kevin K. Kim, Ying Wei, Charles Szekeres et al in 200938 investigated the role of 
epithelial cell integrin links catenin and Smad signaling to promote myofibroblast 
formation and pulmonary fibrosis. The authors explored the role of the prominent 
epithelial integrin in experimental fibrosis by generating mice with lung epithelial 
cell–specific loss of  integrin expression. These mice had a normal acute response to 
bleomycin injury, but they exhibited markedly decreased accumulation of lung 
myofibroblasts and type I collagen and did not progress to fibrosis. Signaling through 
catenin has been implicated in EMT. Integrin was required for catenin 
phosphorylation at tyrosine residue 654 (Y654), formation of the pY654 
catenin/pSmad2 complex, and initiation of EMT. Finally, analysis of lung tissue from 
IPF patients revealed the presence of pY654-catenin/pSmad2 complexes and showed 
accumulation of pY654-catenin in myofibroblasts. These findings demonstrated that 
epithelial integrin–dependent profibrotic crosstalk between catenin and Smad 
signaling and support the hypothesis that EMT is an important contributor to 
pathologic fibrosis. 
.  
Oral Submucous Fibrosis and the role of myofibroblasts 
 
Li X, Ling TY and Gao YJ 200739 studied the effects of arecoline on the 
differentiation of myofibroblasts of oral mucosa. They isolated and cultured oral 
keratinocytes and fibroblasts. The expression of the alpha-smooth muscle actin in the 
fibroblasts was examined by immunohistochemistry and reverse transcriptase 
polymerase chain reaction (RT-PCR). No difference was found in the expression of 
alpha-smooth muscle actin between the fibroblasts that were directly stimulated by 
arecoline and the control. The expression of alpha-smooth muscle actin in the 
keratinocyte and fibroblast-cocultured group was higher than in the control group, 
and higher in fibroblasts cocultured with keratinocytes preprocessed by arecoline than 
in fibroblasts cocultured with keratinocytes without preprocessing with by arecoline. 
They concluded that  differentiation of myofibroblasts from fibroblasts in oral 
submucous fibrosis might be induced by the interaction of arecoline and keratinocyte. 
 
Kundendu Arya Bishen, Raghu Radhakrishnan and  Kapaettu Satyamoorthy in 
200840   studied and analyzed the role of basic fibroblast growth factor in oral 
submucous fibrosis pathogenesis. They studied a series analysis of 30 cases of OSF 
and carried out bFGF expression using immunohistochemistry. Connective tissue 
changes in these cases were corroborated using aldehyde fuchsin and Verhoeff’s 
hematoxylin special stains. They found that bFGF immunoreactivity was found to be 
increased in fibroblasts and in endothelial cells in early OSF cases, while the 
expression of bFGF in stroma increased notably in advanced fibrosis. On staining the 
tissues with Verhoeff’s hematoxylin, the fibers were seen as uniformly distributed 
black-colored fine fibers in the lamina propria of normal mucosa. There was an 
evident change in the nature of fibers in the OSF cases,as there was an increase in the 
coarse fibers in the deeper tissues in the early OSF graded by H&E. Increased bFGF 
expression in early stages of the disease was explainable to an initial injury phase 
because of areca consumption, followed by cellular activation by chemotactic 
cytokines and other growth factors with eventual fibrosis occurring as a result of 
molecular alteration at the cellular level. 
 
K.A. Moutasim, D. Mirza, D. Marsh et al in 200941 studied and investigated the 
role of αvβ6 integrin in the pathogenesis of OSF. The cytokine TGF-β1 is considered 
to have a central role in inducing this myofibroblastic phenotype, and its expression is 
increased in numerous fibrotic conditions. The epithelial-specific integrin αvβ6 is not 
detectable on normal oral keratinocytes but is upregulated during tissue remodelling. 
αvβ6 is regarded as a key activator of TGF-β1 through its interaction with the latency 
associated peptide (LAP) of the cytokine. Immunochemistry was used to examine 
αvβ6 expression in 41 cases of OSF compared with 14 cases of fibroepithelial 
hyperplasia. TGF-β1 activation assays were carried out using a keratinocyte cell line 
genetically modified to express high levels of αvβ6 (VB6). To determine whether 
VB6 cells could induce myofibroblast differentiation, co-culture experiments with 
HFFF2(Human Fetal Foreskin Fibroblasts 2)  fibroblasts were performed.  
Immunochemistry revealed high expression of αvβ6 in 54% of OSF cases. This was 
significantly higher than expression in fibroepithelial hyperplasia (p=0.009). Co-
culture experiments revealed markedly increased SMA expression by HFFF2 cells, 
indicating myofibroblast transdifferentiation. Upregulation of SMA was suppressed 
by inhibiting αvβ6. Myofibroblast transdifferentiation resulted in increased synthesis 
of collagen I. These in vitro findings were confirmed by immunochemistry, which 
demonstrated SMA-positive myofibroblasts in the collagen-rich connective tissue of 
OSF cases. They concluded that αvβ6 integrin is upregulated by keratinocytes in 




Oral squamous cell carcinoma and myofibroblasts 
Hu Yanjia and Jian Xinchun in 200742 investigated the role of epithelial–
mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis. 
Epithelial–mesenchymal transition (EMT) is an indispensable mechanism during 
morphogenesis. Interest and research in EMT are currently at a high level due to its 
important role in cancer and fibrosis. Emerging evidence suggests that EMT is also a 
crucial event in oral squamous cell carcinoma (OSCC).  The keratinocytes secrete a 
variety of profibrotic cytokines, participating in a bi-directional communication 
network with neighboring fibroblasts whereby each cell type influences the 
proliferation/survival of the other. Keratinocyte plays a major role in the pathogenesis 
of OSF, with the capacity to produce TGF-β1, regulate the function and 
differentiation of fibroblasts, and modify cell morphology and gene expression in 
response to injury, all independent of the degree of inflammation. The authors 
highlighted the signaling pathways involved in EMT and the recent advances in the 
study of EMT in OSCC. 
  
Moghadam, M. Khalili, F. Tirgary et al in 20094 evaluated and studied 
myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. They 
studied a sample consisting of three groups, including 40 oral squamous cell 
carcinomas, 15 dysplasias, and 15 sections of normal oral epithelium. Vimentin, 
desmin, and alpha-smooth muscle actin were used to identify myofibroblasts. The 
percentage and intensity of alpha-smooth muscle actin were examined, and positive 
immunostaining was observed in the myofibroblasts of all squamous cell carcinomas; 
however these cells did not stain in the dysplasias or normal epithelium specimens. 
The presence of myofibroblasts was significantly higher in oral squamous cell 
carcinomas compared to both, dysplasias and normal mucosa cases (P < 0.001). A 
significant difference was not observed between the different grades of oral squamous 
cell carcinoma (P = 0.2). These findings show the presence of myofibroblasts in the 
stroma of oral squamous cell carcinoma but not dysplasia and normal mucosa, 
suggesting further investigation to clarify the role of myofibroblasts in the 
carcinogenesis of this tumor. 
PATIENT CHARACTERISTICS 
 
Twenty cases of OSF (Group I), 20 cases of OSCC (Group II) and 10 cases of 
clinically appearing normal mucosa (Group III) were analyzed for immunoreactivity 
of myofibroblasts. All the samples in group I, II and III were taken from the buccal 
mucosa. 
 
DISTRIBUTION OF GENDER AMONG GROUPS 
In Group I 19 (95%) were men and 1(5%) was women. In Group II 15(75%) were 
men and 5(25%) were women. In group III 8 were men (80%) and 2 (20%) were 
women. (Table 1, Graph 1).  
 
DISTRIBUTION OF GENDER AMONG GROUPS 
The age groups are divided into 20to 40 years, 41 to 60 years and 61+ years. In Group 
I out of 20 cases 13(65% ) belonged to age Group 20-40 years and  7(35%) belonged 
to age Group  41-60 years. In Group II out of 20 cases 2(10% ) belonged to age 
Group 20-40 years, 5 cases (25%) belonged to age Group  41-60 years and 13 cases 
(65%) belonged to age Group 61+years. . In Group III out of 10 cases  9(90% ) 
belonged to age Group 20-40 years and  1(10%) belonged to age Group  41-60 years. 
(Table 2, Graph 2) 
 
DISTRIBUTION OF HABITS AMONG GROUP I (OSF) AND GROUP II 
(OSCC) 
In total of 40 cases in group I & II, 31 had habits and details of 9 cases not available. 
Within those who had habits 9.7 %( n=3) had no stain, 51.6 %( n=16) had mild 
staining, 22.6 %( n=7) had moderate staining and 16.1% (n=5) had intense staining. 
Out of 9 who had no habits, 33.3% (n=3) had mild staining, 55.6% (n=5) had mild 





















DISTRIBUTION OF STAINING INTENSITY (SI) OF α-SMA (ALPHA 
SMOOTH MUSCLE ACTIN) AMONG 3 GROUPS: 
                              α-SMA revealed positivity in group I, II and III. In Group I and 
Group II cases showed 85% staining for α-SMA, whereas in Group III, positive 
staining was observed 30%.  
In Group I out of 20 OSF cases 30 %( n=6) cases have a score of 3 (SI3), 20 %( n=4) 
cases have a score of 2 (SI2), 35 %( n=7) cases have a score of 1 (SI1), and 15% 
(n=3) cases have a score of 0 (SI0). Group II out of 20 cases 20 %( n=4) cases have a 
score of 3 (SI3), 30 %( n=6) cases have a score of 2 (SI2),  35 %( n=7) cases have a 
score of 1 (SI1), and 15% (n=3) cases have a score of 0 (SI0). In Group III out of 10 
normal cases 30 %( n=3) cases have a score of 0 (SI0) and 70 %( n=7) cases have a 
score of 1 (SI1). (Table 4, Graph 4)  
 
DISTRIBUTION OF STAINING INTENSITY AMONG DIFFERENT OSF 
GRADINGS 
Total 20 cases of OSF, 6 cases belonged to Grade I, 10 cases belonged to Grade II 
and 4 cases belonged to Grade III. In Grade I 16.7% (n=1) have a score of 0 (SI0), 
50% (n=3) have a score of 1 (SI1),  16.7 % (n=1) have a score of 2 (SI2) and 16.7 %( 
n=1) have a score of 3 (SI3). In Grade II 40 %( n=4) have a score of1 (SI1), 30 %( 
n=3) have a score of 2 (SI2), and 30% (n=3) have a score of 3 (SI3), In Grade III 50 
%( n=2) have a score of 0 (SI0) and 50 % (n=2) have a score of 3 (SI3) (Table 5, 
Graph 5) 
 
DISTRIBUTION OF STAINING INTENSITY AMONG DIFFERENT OSCC 
GRADINGS 
Total 20 cases of OSCC, 13 cases belonged to well differentiated group, 3 cases 
belonged to moderately differentiated and 4 cases belonged to poorly differentiated. 
In well differentiated group, 23.1% (n=3) have a score of 0 (SI0), 23.1% (n=3) have a 
score of 1 (SI1), 23.1 % (n=3) have a score of 2 (SI2) and 30.8 %( n=4) have a score 
of 3 (SI3). In moderately differentiated group II 66.7 %( n=2) have a score of1 (SI1) 
and 33.3 %( n=1) have a score of 2 (SI2) In poorly differentiated group  50 %( n=2) 
have a score of 1 (SI1) and 50 % (n=2) have a score of 2 (SI2) (Table 6, Graph 6) 
 
KAPPA STASTISTIC VALUE 
 
The inter-observer agreement for the staining intensity of stain for all the 3 groups 







PERCENTAGE OF IMMUNOPOSITIVE CELLS- LABELING INDEX (LI) 
 
DISTRIBUTION OF LABELING INDEX (LI) OF α-SMA (ALPHA SMOOTH 
MUSCLE ACTIN) AMONG 3 GROUPS: 
α-SMA revealed positivity in group I, II and III. In Group I and Group II cases 
showed 85% staining for α-SMA, whereas in Group III, positive staining was 
observed 40%.  
In Group I out of 20 OSF cases 5 %( n=1) cases have a score of 3 (LI3), 40 %( n=8) 
cases have a score of 2 (LI2), 40 %( n=8) cases have a score of 1 (LI1), and 15% 
(n=3) cases have a score of 0 (LI0). Group II out of 20 cases 15 %( n=3) cases have a 
score of 0 (LI0) and 85 %( n=17) cases have a score of 1 (LI1). In Group III out of 10 
normal cases 60 %( n=6) cases have a score of 0 (LI0) and 40 %( n=4) cases have a 
score of 1 (LI1). (Table 7, Graph 7)  
 
DISTRIBUTION OF LABELING INDEX (LI) AMONG DIFFERENT OSF 
GRADINGS 
Total 20 cases of OSF, 6 cases belonged to Grade I, 10 cases belonged to Grade II 
and 4 cases belonged to Grade III. In Grade I 16.7% (n=1) have a score of 0 (LI0), 
50% (n=3) have a score of 1 (LI1) and 33.3 % (n=2) have a score of 2 (LI2). In Grade 
II 50 %( n=5) have a score of1 (LI1), 40 %( n=4) have a score of 2 (LI2), and 10% 
(n=1) have a score of 3 (SI3). In Grade III 50 %( n=2) have a score of 0 (LI0) and 50 
% (n=2) have a score of 2 (LI2) (Table 8, Graph 8) 
DISTRIBUTION OF STAINING INTENSITY AMONG DIFFERENT OSCC 
GRADINGS 
Total 20 cases of OSCC, 13 cases belonged to well differentiated group, 3 cases 
belonged to moderately differentiated and 4 cases belonged to poorly differentiated. 
In well differentiated group, 23.1% (n=3) have a score of 0 (LI0) and 76.9 % (n=10) 
have a score of 1 (LI1). In moderately differentiated group 100 %( n=3) have a score 
of1 (LI1).  In poorly differentiated group 100 %( n=4) have a score of 1 (LI1) (Table 


















DISTRIBUTION OF STAINING INDEX AMONG THE GROUPS. 
Using Kruskal-Wallis test the comparison among groups derived, there is a 
significant difference in the expression of myofibroblasts (p=0.004< 0.05) (Table 10, 
Graph 10) 
COMPARISON OF STAINING INDEX  BETWEEN GROUP I AND GROUP 
III 
 In OSF, 15% of the cases showed no staining while 40% mild staining, 20% 
moderate staining and 25% of the cases had intense staining in connective tissue. In 
normal mucosa, 40% exhibited mild staining and no staining was seen in 60% of the 
cases. The result is statistically significant (p = 0.005<0.05) (Table 11, Graph 11) 
COMPARISON OF STAINING INDEX BETWEEN GROUP II AND GROUP 
III 
 In OSCC, 15% of the cases showed no staining while 65% mild staining and 
20% moderate staining in connective tissue. In normal mucosa, 40% exhibited mild 
staining and no staining was seen in 60% of the cases. The result is statistically 
significant (p = 0.019<0.05) (Table 12, Graph 12) 
 
COMPARISON OF STAINING INTENSITY BETWEEN GROUP I AND 
GROUP II 
 In OSF group, 15% of the cases showed no staining while 40% mild staining, 
20% moderate staining, and 25% of the cases had intense staining in connective 
tissue. In OSCC group, 15% of the cases showed no staining while 65% mild staining 
and 20% moderate staining in connective tissue. As both the lesions expressing 
myofibroblasts, the result is statistically not significant (p = 0.157) (Table 13, Graph 
13) 
 
COMPARISON OF STAINING IN DIFFERENT OSF GRADING 
Total 20 cases of OSF, 6 cases belonged to Grade I, 10 cases belonged to Grade II 
and 4 cases belonged to Grade III. In Grade I 16.7% (n=1) showed no stain, 50% 
(n=3) showed mild stain 16.7% (n=1) moderate and 16.7 %( n=1) showed intense 
staining. In Grade II 50 %( n=5) showed mild staining 20 %( n=2) showed moderate 
and 30% (n=3) showed intense staining. In Grade III 50 %( n=2) showed no stain, 
25% (n=1) showed moderate and 25 %( n=1) showed intense staining. (Table 14, 
Graph 14) 
 
COMPARISON OF STAINING IN DIFFERENT OSCC GRADING 
In total 20 cases of OSCC, 13 belonged to well differentiated, 3 belonged to 
moderately differentiated and 4 belonged to poorly differentiated. In well 
differentiated group 23.1% (n=3) showed no stain, 46.2% showed mild stain and 
30.8% showed moderate staining. In OSCC moderately differentiated 100% (n=3) 
showed mild staining. In OSCC poorly differentiated 100% (n=4) showed mild 
staining (Table 15, Graph 15) 
Myofibroblasts may be morphologically and immunologically identified 
through the expressed cytoskeletal proteins. The myofibroblasts are contractile cells 
expressing α SMA(smooth muscle actin). They are smooth muscle like cells and are 
capable of augmenting and down-regulating the inflammatory response by secreting 
soluble mediators of inflammation.23 They are induced by TGFβ,41, 23 a potent pro-
inflammatory and pro-fibrotic cytokine that regulates the balance between collagen 
deposition and degradation in oral submucous fibrosis.  Owing to the various 
functions of the myofibroblasts and its active role in formation and repair of 
extracellular matrix healing, this  study was undertaken to identify the relationship of 
myofibroblasts to the various grades of  oral submucous fibrosis, oral squamous cell 
carcinoma compared to normal mucosa using α SMA which is expressed by 
myofibroblasts. 
Twenty cases each of oral submucous fibrosis and oral squamous cell 
carcinoma archival tissue and ten normal mucosa  obtained during impaction removal 
procedures were utilized for the study. The distribution of genders in the study groups 
was 4:1 (Males: Females). In the oral submucous fibrosis group the gender 
distribution is 19:1(Males: Females). The male preponderance among oral submucous 
fibrosis has been documented in several studies from South India.7  
The age distribution of oral submucous fibrosis as observed was between 20-
40 years. Oral submucous fibrosis commonly occurs in the age group of 20-40 years7. 
Similarly the occurrence of oral squamous cell carcinoma commonly occurs among 
older age groups as seen in this study.12 
Staining intensity did not show any difference among the three study groups. 
It was further observed that the staining intensity 3 (30%) expression was seen more 
in oral submucous fibrosis than in oral squamous cell carcinoma(20%). This finding 
could be probably explained by the fact that  altered wound healing process of the 
oral mucosa could have occured after chronic sustained injury and thus  resulting in 
fibrosis. This could also be due to hypersensitivity response caused by arecoline and 
the resultant persistent inflammatory response  in oral submucous fibrosis, which acts 
as an initiator in the activation of fibroblasts culminating in fibrosis.13 On analyzing 
the staining intensity among grades of oral submucous fibrosis it was observed that 
staining intensity progressively increased from early oral submucous fibrosis to 
advanced oral submucous fibrosis. This finding is consistent with the findings of 
Angadi et al3, though the classification employed in that study is different1, we 
employed a more clinically relevant classification.10 
Higher staining intensity was observed among well differentiated oral 
squamous cell carcinoma group while the moderate and poorly differentiated groups 
of oral squamous cell carcinoma show mild staining intensity. This suggests that 
myofibroblasts are stimulated during the repair of extracellular matrix  and are 
capable of augmenting and down-regulating the inflammatory response by secretion 
of these soluble mediators of inflammation like prostaglandins, 
hydroxyeicosatetraenoic acids (HETEs), growth factors TGF-β and cytokines 
interleukin 1, interleukin 6, TNF-α, inteleukin 10.23 
 The percentage of positively stained cells as indicated by the labeling index 
showed the labeling index grades of LI 2 and 3 were observed in oral submucous 
fibrosis and not in oral squamous cell carcinoma or normal mucosa. The chronic 
inflammation and continuous tissue remodeling in oral submucous fibrosis as well as 
chronic sustaining injury to factors such as arecoline and micro trauma could cause 
the transient or continuous differentiation of fibroblast from undifferentiated stem cell 
or a differentiated fibroblast pool. Our study confers with findings of Angadi et al3 
The labeling index among the various grades of oral submucous fibrosis were 
studied. In Grade II and Grade III oral submucous fibrosis 50% of the cases show 
labeling index score of 2 and 3 while in Grade I oral submucous fibrosis 33.3% of 
cases show  labeling index score 2. This indicates that with the increase of stimulus 
and the severe grade of the disease, more amount of myofibroblasts differentiation 
occurs.23, 3 However the difference between the grades was not statistically 
significant. When comparing the labeling index (LI) within the grades of oral 
squamous cell carcinoma there was no significant difference.  Thus the expression 
pattern of α SMA in our study indicates that differentiation of oral squamous cell 
carcinoma does not correlate with the differentiation of myofibroblasts. 
Staining index among the study group was studied. There was statistically 
significant difference in the pattern of staining index among the study groups. Intense 
staining of α SMA was observed in oral submucous fibrosis and moderate staining 
was seen in both oral submucous fibrosis and oral squamous cell carcinoma. Normal 
mucosa had mild staining index. This could be the effect of mild inflammation in 
normal mucosa. The intense staining in oral submucous fibrosis were similar to the 
findings of Angadi et al3. Though 65% cases of oral squamous cell carcinoma showed 
a mild Staining Index and 20% cases had moderate Staining Index, none had intense 
Staining Index. The absence of intense Staining Index in oral squamous cell 
carcinoma needs to be studied further.  
On comparing the Staining Index between oral submucous fibrosis and normal 
mucosa, it is observed that 85% of oral submucous fibrosis cases showing positivity 
while 40% of cases in normal mucosa show positivity of α SMA. The uniform mild 
expression in both the groups, probably could be a result of the mild chronic 
inflammation in both these conditions. 
On comparing the staining index between oral squamous cell carcinoma and 
normal mucosa, 65% of oral squamous cell carcinoma cases showed mild staining 
index and 20% of cases showed moderate staining index while in normal mucosa 
40% cases showed mild staining index. However it was statistically significant. The 
uniformity in expression probably relates to the chronic inflammation that exists in 
both the conditions.  
There is no significant difference of staining index between oral submucous 
fibrosis and squamous cell carcinoma. However 24% of cases exhibited intense 
staining in oral submucous fibrosis while no cases of oral squamous cell carcinoma 
had intense staining index. This indicates that oral submucous fibrosis had more 
myofibroblasts expression than oral squamous cell carcinoma probably due to failure 
of healing and continuous fibrosis3.The staining index did not considerably vary 
within the grades of the oral submucous fibrosis.  
Our results suggest that persistent, chronic inflammation leads to formation of 
a subset of fibroblastic population-myofibroblasts. The chronic inflammatory 
mediators such as TGFβ and αvβ6 integrin could cause more numbers as well as 
increased intensity or wide functional ability of myofibroblasts. Though our study 
failed to demonstrate a statistically significant difference between grades of oral 
submucous fibrosis, a trend that is suggestive of such a phenomenon was seen. 
Further studies will shed more light on the pathogenesis of oral submucous fibrosis 
with reference to myofibroblasts. 
 
Summary and conclusion 
 The aim of the study was to evaluate expression of myofibroblasts in oral 
submucous fibrosis, oral squamous cell carcinoma and normal mucosa. 
 In this study the immunohistochemical analysis was done with α-SMA 
(smooth muscle actin ). Total of 50 blocks from archives were taken. 
 20 cases of oral submucous fibrosis(Group I), 20 cases of oral squamous cell 
carcinoma(Group II)  and 10 cases of normal mucosa. 
 It was observed that Staining Intensity score (S.I- 3) was seen more in oral 
submucous fibrosis than in oral squamous cell carcinoma. 
 Staining intensity among grades of oral submucous fibrosis progressively 
increased from early oral submucous fibrosis to advanced oral submucous 
fibrosis, but it was not statistically significant. 
 Among the grades of oral squamous cell carcinoma, higher staining intensity 
was observed among well differentiated oral squamous cell carcinoma while 
others show mild staining intensity. 
 As determined by labeling index, more percentage of cells expressing α SMA 
in oral submucous fibrosis than in oral squamous cell carcinoma and Normal 
mucosa 
 When comparing the Staining Index between oral submucous fibrosis and 
normal mucosa, there is a significant difference. 
Our results suggest that oral submucous fibrosis actually represents an abnormal 
healing process in response to chronic mechanical and chemical irritation because of 
areca nut chewing as demonstrated by the increased incidence of myofibroblasts in 
this disease. Additionally, as myofibroblasts are responsible for producing a variety 
of factors that are involved in the fibrotic processes, they could be the key link in the 
pathogenesis of oral submucous fibrosis. Interruption of development, recruitment or 
activation could provide a unique therapeutic approach to combat fibrosis. 
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n=20 19 1 
0.210 
% 95 5 
Group II 
n=20 15 5 
% 75 25 
Group III 
n=10 8 2 
% 80 20 





























TABLE 2 : DISTRIBUTION OF AGE IN THE STUDY GROUPS (n=50) 
AGE (in years) 
GROUP I GROUP II GROUP III p 
VALUE 
n=20 % n=20 % n=10 % 
20-40 13 65 2 10 9 90 
0.000* 41-60 7 35 5 25 1 10 
>61 0 0 13 65 0 0 
  
*p value < 0.05 was considered to be statistically significant 
 
GRAPH 2 : DISTRIBUTION OF AGE IN THE STUDY GROUPS (n=50)  







































SMK CHW ALC CHW+ SMK 
SMK+ 
ALC CHW+ALC ALL pVALUE 




% n=1 % n=10 % n=4 % 
0.597 
NO 
STAIN 0 0 0 0 1 50 0 0 0 0 2 20 0 0 
MILD 4 80 3 50 0 0 3 100 1 100 3 30 2 50 
MODER
ATE 1 20 2 33.3 1 50 0 0 0 0 2 20 1 25 
HIGH 0 0 1 16.7 0 0 0 0 0 0 3 30 1 25 
(Details of 9 cases not available) 
 































TABLE 4 : DISTRIBUTION OF STAINING INTENSITY AMONG                                   
THE GROUPS (n=50) 
 
STAINING INTENSITY SI 0  SI 1 SI 2 SI 3 p VALUE 
GROUP I n=20 3 7 4 6 
0.156 
% 15 35 20 30 
GROUP II n=20 3 7 6 4 % 15 35 30 20 
GROUP III n=10 3 7 0 0 % 30 70 0 0 
 
GRAPH 4 : DISTRIBUTION OF STAINING INTENSITY AMONG                             








No staining scored as 0 (SI 0) 
Staining visible only at 40X scored as 1 (SI 1) 
Staining visible at only at 10X not in 4X scored as 2 (SI 2) 

























TABLE 5: DISTRIBUTION OF STAINING INTENSITY AMONG DIFFERENT  
OSF GRADINGS (n=20) 
 
STAINING 
INTENSITY SI 0 SI 1 SI 2 SI 3 p VALUE 
OSF GRADE I 
n=6 1 3 1 1 
0.182 
% 16.7 50 16.7 16.7 
OSF GRADE II 
n=10 0 4 3 3 
% 0 40 30 30 
OSF GRADE 
III 
n=4 2 0 0 2 
% 50 0 0 50 
 
GRAPH 5: DISTRIBUTION OF STAINING INTENSITY AMONG DIFFERENT  
OSF GRADINGS (n=20) 
 
   
 
No staining scored as 0 (SI 0) 
Staining visible only at 40X scored as 1 (SI 1) 
Staining visible at only at 10X not in 4X scored as 2 (SI 2) 

















TABLE 6: DISTRIBUTION OF STAINING INTENSITY AMONG DIFFERENT  
OSCC GRADINGS (n=20) 
 
STAINING INTENSITY SI 0  SI 1 SI 2 SI 3 p VALUE 
OSCC-WELL 
DIFFERENTIATED 












n=3 0 2 1 0 
% 0 66.7 33.3 0 
OSCC POORLY 
DIFFERENTIATED 
n=4 0 2 2 0 
% 0 50 50 0 
 
GRAPH 6: DISTRIBUTION OF STAINING INTENSITY AMONG DIFFERENT  




No staining scored as 0 (SI 0) 
Staining visible only at 40X scored as 1 (SI 1) 
Staining visible at only at 10X not in 4X scored as 2 (SI 2) 


















TABLE 7 : DISTRIBUTION OF PERCENTAGE OF CELLS AMONG                             
THE GROUPS (n=50) 
PERCENTAGE OF CELLS LI 0  LI 1 LI 2 LI 3 p VALUE 
GROUP I n=20 3 8 8 1 
0.000* 
% 15 40 40 5 
GROUP II n=20 3 17 0 0 % 15 85 0 0 
GROUP III n=10 6 4 0 0 % 60 40 0 0 
 
 
GRAPH 7 : DISTRIBUTION OF PERCENTAGE OF CELLS AMONG                             





0 positive cells scored as 0 (LI 0) 
1-25% of positive cells scored as 1 (LI 1) 
25-50% of positive cells scored as 2 (LI 2) 


























TABLE 8: DISTRIBUTION OF PERCENTAGE OF CELLS AMONG DIFFERENT 





CELLS LI 0 LI 1 LI 2 LI 3 p VALUE 
OSF GRADE I 
n=6 1 3 2 0 
0.242 
% 16.7 50 33.3 0 
OSF GRADE II 
n=10 0 5 4 1 
% 0 50 40 10 
OSF GRADE III 
n=4 2 0 2 0 
% 50 0 50 0 
 
GRAPH 8: DISTRIBUTION OF PERCENTAGE OF CELLS AMONG DIFFERENT 
OSF GRADINGS (n=20 
   
0 positive cells scored as 0 (LI 0) 
1-25% of positive cells scored as 1 (LI 1) 
25-50% of positive cells scored as 2 (LI 2) 




















TABLE 9: DISTRIBUTION OF PERCENTAGE OF CELLS AMONG DIFFERENT 
OSCC GRADINGS (n=20) 
 
PERCENTAGE OF CELLS LI 0  LI 1 LI 2 LI 3 p VALUE 
OSCC-WELL 
DIFFERENTIATED 












n=3 0 3 0 0 
% 0 100 0 0 
OSCC POORLY 
DIFFERENTIATED 
n=4 0 4 0 0 
% 0 100 0 0 
 
TABLE 9: DISTRIBUTION OF PERCENTAGE OF CELLS AMONG DIFFERENT 





0 positive cells scored as 0 (LI 0) 
1-25% of positive cells scored as 1 (LI 1) 
25-50% of positive cells scored as 2 (LI 2) 




















TABLE 10 : DISTRIBUTION OF STAINING INDEX AMONG                             
THE GROUPS (n=50) 
STAINING INDEX NO STAIN MILD MODERATE INTENSE p VALUE 
GROUP I n=20 3 8 4 5 
0.004* 
% 15 40 20 25 
GROUP II n=20 3 13 4 0 % 15 65 20 0 
GROUP III n=10 6 4 0 0 % 60 40 0 0 
*p value < 0.05 was considered to be statistically significant 
GRAPH 10 : DISTRIBUTION OF STAINING INDEX AMONG THE GROUPS 
  
STAINING INDEX 
GROUP I-OSF  
GROUP II-OSCC 



























TABLE 11: COMPARISON OF STAINING INDEX BETWEEN GROUP I  
















n=20 15 40 20 25 0.005* 
Group III 
n=10 60 40 0 0  
*p value < 0.05 was considered to be statistically significant 
GRAPH 11: COMPARISON OF STAINING INDEX BETWEEN GROUP I  


































*p value < 0.05 was considered to be statistically significant 
GRAPH 12: COMPARISON OF STAINING INDEX IN BETWEEN GROUP II 












































n=20 15 65 20 
0.019* 
Group III 
n=10 60 40 0 
 TABLE 13: COMPARISON OF STAINING INDEX BETWEEN  













n=20 15 40 20 25 
0.157 
Group II 
n=20 15 65 20 0 
 
GRAPH 13: COMPARISON OF STAINING INDEX BETWEEN  
GROUP I AND GROUP II 
 






























TABLE 14: DISTRIBUTION OF STAINING INDEX AMONG DIFFERENT  
OSF GRADINGS (n=20) 
 
STAINING INDEX NO STAIN MILD MODERATE INTENSE p VALUE 
OSF GRADE I 
n=6 1 3 1 1 
0.309 
% 16.7 50 16.7 16.7 
OSF GRADE II 
n=10 0 5 2 3 
% 0 50 20 30 
OSF GRADE III 
n=4 2 0 1 1 
% 50 0 25 25 
 



























TABLE 15: DISTRIBUTION OF STAINING INDEX AMONG DIFFERENT  
OSCC GRADINGS (n=20) 
 
STAINING INDEX NO STAIN MILD MODERATE p VALUE 
OSCC-WELL 
DIFFERENTIATED 












n=3 0 3 0 
% 0 100 0 
OSCC POORLY 
DIFFERENTIATED 
n=4 0 4 0 
% 0 100 0 
 
GRAPH 15: DISTRIBUTION OF STAINING INDEX AMONG DIFFERENT  
OSCC GRADINGS 
 

































Figure 3  
 

























 α-SMA Positive staining of OSF-40X 
 
Figure 9 








 α-SMA Positive staining of OSCC-40X 
 
Figure 11 





Figure 12  
 α-SMA Positive staining of Normal mucosa-40X 
 
